Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

REGN Stock Forecast, Price Targets, Chart, Dividends & Analysis

Regeneron Pharmaceuticals Inc. logo

Regeneron Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

996.05
 
USD
  
-16.77
  
(-1.66%)
Previous close: 1012.82  Open: 1011.22  Bid: 992.88  Ask: 1019.0
52 week range    
769.19   
   1,211.20
Mkt Cap: 115,406 M  Avg Vol (90 Days): 527,231
Peers   
AMGN / 
ALNY / 
BIIB / 
SNY / 
NVS / 
Last updated: Tuesday 8th October 2024

Stock Rankings

53
MarketXLS Rank
80
Value
23
Technical
57
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ALNY

35 B-468266.77

AMGN

0.0282172 B55.31317.45

BIIB

28 B24.37183.34

JNJ

0.0309390 B24.94159.53

NVS

SNY

Financials

REGN Income Statement

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
Amortization of intangibles916 M1,039 M
Basic EPS from continuing operations3.466.178.5511.2722.6519.3832.6576.440.5137.05
Basic EPS total3.466.178.5511.2722.6519.3832.6576.440.5137.05
Basic weighted shares outstanding101 M103 M105 M106 M108 M109 M108 M106 M107 M107 M
Cost of sales129 M242 M195 M203 M254 M403 M1,120 M2,438 M1,560 M1,816 M
Depreciation53 M75 M105 M145 M
DepreciationAndAmortization53 M75 M105 M145 M
Diluted EPS total3.075.527.710.3421.2918.4630.5271.9738.2234.77
Diluted normalized net income/share3.075.527.710.3421.2918.4630.5271.9738.2234.77
Diluted weighted shares outstanding113 M115 M116 M116 M115 M115 M115 M112 M114 M114 M
GainOnSaleOfSecurity1 M8 M
GeneralAndAdministrativeExpense519 M839 M1,178 M1,320 M1,556 M1,342 M1,346 M1,825 M2,116 M2,631 M
Gross operating profit2,691 M3,862 M4,666 M5,670 M6,457 M6,155 M7,377 M13,634 M10,613 M11,301 M
Income before tax761 M1,225 M1,330 M2,079 M2,554 M2,429 M3,810 M9,326 M4,859 M4,199 M
Income taxes423 M589 M434 M880 M109 M313 M297 M1,251 M520 M246 M
Interest income-14 M-7 M-25 M
InterestExpenseNonOperating37 M14 M25 M28 M30 M57 M57 M59 M73 M
InterestIncomeOperating46 M160 M496 M
MiscOtherSpecialCharges-25 M-13 M6 M24 M47 M250 M291 M436 M179 M225 M
Net income from total operations338 M636 M896 M1,199 M2,444 M2,116 M3,513 M8,075 M4,338 M3,954 M
NetIncomeCommonStockholders490 M938 M1,106 M1,199 M2,444 M2,478 M3,513 M8,171 M4,338 M3,954 M
NetIncomeContinuousOperations338 M636 M896 M1,199 M2,444 M2,116 M3,513 M8,075 M4,338 M3,954 M
NetNonOperatingInterestIncomeExpense-37 M-14 M-7 M-25 M-28 M-30 M-57 M-57 M-101 M-423 M
Normalized income495 M796 M864 M1,351 M2,017 M1,919 M3,010 M3,346 M
Operating income824 M1,252 M1,331 M2,080 M2,534 M2,210 M3,577 M8,947 M4,739 M4,047 M
Operating income before depreciation (EBITDA)851 M1,300 M1,435 M2,249 M2,730 M2,670 M4,103 M9,669 M5,260 M4,693 M
OperatingExpense1,791 M2,459 M3,230 M3,396 M3,742 M3,583 M3,801 M4,639 M5,619 M7,068 M
Other income net25 M13 M-6 M-24 M-47 M-249 M-291 M-436 M-236 M-457 M
OtherGandA519 M839 M1,178 M1,320 M1,556 M1,342 M1,346 M1,825 M2,116 M2,631 M
OtherImpairmentOfCapitalAssets29 M
OtherOperatingExpenses-28 M-60 M-46 M-49 M-51 M-209 M-280 M-46 M-90 M-2 M
RentAndLandingFees14 M15 M17 M4 M5 M
Research & development expense1,271 M1,621 M2,052 M2,075 M2,186 M2,450 M2,735 M2,860 M3,593 M4,439 M
ResearchExpense1,271 M1,621 M2,052 M2,075 M2,186 M2,450 M2,735 M2,860 M3,593 M4,439 M
Revenue per share14 M14 M14 M930 M1,053 M
SalariesAndWages322 M459 M
Selling Gen & administrative expense519 M839 M1,178 M1,320 M1,556 M1,342 M1,346 M1,825 M2,116 M2,631 M
Total Income available for interest expense (EBIT)799 M1,225 M1,330 M2,104 M2,582 M2,459 M3,867 M9,383 M4,918 M4,272 M
Total common shares outstanding205 M210 M212 M215 M219 M220 M107 M109 M109 M110 M
Total net income338 M636 M896 M1,199 M2,444 M2,116 M3,513 M8,075 M4,338 M3,954 M
Total ordinary shares108 M108 M108 M108 M108 M108 M108 M108 M108 M108 M
Total revenues2,820 M4,104 M4,860 M5,872 M6,711 M6,558 M8,497 M16,072 M12,173 M13,117 M
TotalExpenses1,920 M2,701 M3,425 M3,598 M3,996 M3,986 M4,429 M6,413 M7,179 M8,884 M
TotalRevenue2,820 M4,104 M4,860 M5,872 M6,711 M6,558 M8,497 M16,072 M12,173 M13,117 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University